Greenwich Lifesciences Inc
GLSI11.100USD
+0.010+0.09%
交易中 （美東）報價延遲15分鐘
146.44M總市值
虧損本益比TTM
關於 Greenwich Lifesciences Inc 公司
Greenwich LifeSciences, Inc. 是一家臨牀階段的生物製藥公司。該公司專注於開發 GP2，這是一種用於預防乳腺癌復發的免疫療法，適用於之前接受過手術的患者。GP2 是人類表皮生長因子受體 2 (HER2)/neu 蛋白的 9 個氨基酸跨膜肽，這是一種在多種常見癌症中表達的細胞表面受體蛋白。GP2 與粒細胞-巨噬細胞集落刺激因子結合使用，以誘導 GP2 肽特異性免疫。GP2 治療通過皮內注射給藥，在給藥時將 GP2 肽和 GM-CSF 混合。其癌症免疫療法旨在刺激個體的免疫系統選擇性地攻擊癌細胞，同時不影響正常細胞，或傳遞免疫系統成分以抑制癌症擴散。該公司已開始 III 期臨牀試驗，Flamingo-01 是一種用於預防乳腺癌復發的免疫療法。
公司簡介
公司代碼GLSI
公司名稱Greenwich Lifesciences Inc
上市日期Sep 25, 2020
CEOMr. Snehal Patel
員工數量4
證券類型Ordinary Share
年結日Sep 25
公司地址3992 Bluebonnet Dr, Building 14
城市STAFFORD
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編77477
電話12034343290
網址https://greenwichlifesciences.com
公司代碼GLSI
上市日期Sep 25, 2020
CEOMr. Snehal Patel
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Snehal Patel
Mr. Snehal Patel
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
5.57M
+0.33%
Mr. David B. Mcwilliams
Mr. David B. Mcwilliams
Independent Chairman of the Board
Independent Chairman of the Board
620.33K
--
Mr. Kenneth Hallock
Mr. Kenneth Hallock
Independent Director
Independent Director
397.33K
--
Mr. Eric Rothe
Mr. Eric Rothe
Independent Director
Independent Director
313.25K
--
Dr. Jaye Thompson, Ph.D.
Dr. Jaye Thompson, Ph.D.
Vice President - Clinical & Regulatory Affairs
Vice President - Clinical & Regulatory Affairs
--
--
Dr. F. Joseph Daugherty, M.D.
Dr. F. Joseph Daugherty, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Snehal Patel
Mr. Snehal Patel
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
5.57M
+0.33%
Mr. David B. Mcwilliams
Mr. David B. Mcwilliams
Independent Chairman of the Board
Independent Chairman of the Board
620.33K
--
Mr. Kenneth Hallock
Mr. Kenneth Hallock
Independent Director
Independent Director
397.33K
--
Mr. Eric Rothe
Mr. Eric Rothe
Independent Director
Independent Director
313.25K
--
Dr. Jaye Thompson, Ph.D.
Dr. Jaye Thompson, Ph.D.
Vice President - Clinical & Regulatory Affairs
Vice President - Clinical & Regulatory Affairs
--
--
Dr. F. Joseph Daugherty, M.D.
Dr. F. Joseph Daugherty, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Patel (Snehal)
41.67%
McWilliams (David B)
4.64%
Hallock (Kenneth)
2.97%
BlackRock Institutional Trust Company, N.A.
2.41%
Rothe (Eric)
2.34%
Other
45.97%
持股股東
持股股東
佔比
Patel (Snehal)
41.67%
McWilliams (David B)
4.64%
Hallock (Kenneth)
2.97%
BlackRock Institutional Trust Company, N.A.
2.41%
Rothe (Eric)
2.34%
Other
45.97%
股東類型
持股股東
佔比
Individual Investor
54.28%
Investment Advisor
5.86%
Investment Advisor/Hedge Fund
2.35%
Hedge Fund
0.85%
Pension Fund
0.20%
Research Firm
0.15%
Bank and Trust
0.05%
Other
36.26%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
105
8.52M
63.74%
-338.41K
2025Q1
106
8.50M
64.50%
-388.04K
2024Q4
96
8.34M
63.41%
-410.99K
2024Q3
92
8.47M
64.65%
-203.33K
2024Q2
92
8.33M
64.66%
+241.77K
2024Q1
97
7.76M
60.42%
-184.06K
2023Q4
95
7.62M
59.30%
-311.10K
2023Q3
103
7.60M
59.17%
-679.19K
2023Q2
102
7.68M
59.81%
-652.02K
2023Q1
106
7.87M
61.24%
-314.63K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Patel (Snehal)
5.57M
41.67%
+18.10K
+0.33%
Apr 25, 2025
McWilliams (David B)
620.33K
4.64%
--
--
Apr 11, 2025
Hallock (Kenneth)
397.33K
2.97%
--
--
Apr 11, 2025
BlackRock Institutional Trust Company, N.A.
321.62K
2.41%
-5.91K
-1.81%
Mar 31, 2025
Rothe (Eric)
313.25K
2.34%
--
--
Apr 11, 2025
The Vanguard Group, Inc.
270.31K
2.02%
-4.68K
-1.70%
Mar 31, 2025
Thompson (Jaye L)
264.14K
1.98%
+1.00K
+0.38%
Nov 21, 2024
Geode Capital Management, L.L.C.
137.01K
1.02%
+2.94K
+2.19%
Mar 31, 2025
Daugherty (Frank Joseph)
90.13K
0.67%
--
--
Apr 11, 2025
DIM Funds SICAV S.A.
87.00K
0.65%
--
--
Jun 30, 2024
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
ProShares UltraPro Russell2000
佔比0%
ProShares Hedge Replication ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
